BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8232361)

  • 21. [Prevalence of mental disorders in persons with Parkinson's disease].
    de Rijk C; Bijl RV
    Ned Tijdschr Geneeskd; 1998 Jan; 142(1):27-31. PubMed ID: 9556986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life in relation to mood, coping strategies, and dyskinesia in Parkinson's disease.
    Montel S; Bonnet AM; Bungener C
    J Geriatr Psychiatry Neurol; 2009 Jun; 22(2):95-102. PubMed ID: 19150974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features of 35 patients with Parkinson's disease displaying REM behavior disorder.
    Ozekmekçi S; Apaydin H; Kiliç E
    Clin Neurol Neurosurg; 2005 Jun; 107(4):306-9. PubMed ID: 15885389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parkinson's disease: a preliminary study of yohimbine challenge in patients with anxiety.
    Richard IH; Szegethy E; Lichter D; Schiffer RB; Kurlan R
    Clin Neuropharmacol; 1999; 22(3):172-5. PubMed ID: 10367182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The presence of depression and anxiety in Parkinson's disease.
    Mercury MG; Tschan W; Kehoe R; Kuechler A
    Dis Mon; 2007 May; 53(5):296-301. PubMed ID: 17656191
    [No Abstract]   [Full Text] [Related]  

  • 26. Predicting beneficial response to a protein-redistribution diet in fluctuating Parkinson's disease.
    Giménez-Roldán S; Mateo D
    Acta Neurol Belg; 1991; 91(4):189-200. PubMed ID: 1746241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative study of "on-off" fluctuations in the ocular motor system in Parkinson's disease.
    Gibson JM; Kennard C
    Adv Neurol; 1987; 45():329-33. PubMed ID: 3825705
    [No Abstract]   [Full Text] [Related]  

  • 28. Validity and reliability of the Geriatric Anxiety Inventory in Parkinson's disease.
    Matheson SF; Byrne GJ; Dissanayaka NN; Pachana NA; Mellick GD; O'Sullivan JD; Silburn PA; Sellbach A; Marsh R
    Australas J Ageing; 2012 Mar; 31(1):13-6. PubMed ID: 22417148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rasch analysis of anxiety scales in Parkinson's disease.
    Forjaz MJ; Martinez-Martin P; Dujardin K; Marsh L; Richard IH; Starkstein SE; Leentjens AF
    J Psychosom Res; 2013 May; 74(5):414-9. PubMed ID: 23597329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible involvement of attention processes in Parkinson's disease.
    Girotti F; Grassi MP; Carella F; Soliveri P; Musicco M; Lamperti E; Caraceni T
    Adv Neurol; 1987; 45():425-9. PubMed ID: 3825721
    [No Abstract]   [Full Text] [Related]  

  • 31. [Thinking disorders in patients with Parkinson's disease].
    Smiljković P; Ocić G
    Srp Arh Celok Lek; 1989; 117(5-6):291-300. PubMed ID: 2595458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of diagnostic criteria for apathy in Parkinson's disease.
    Drijgers RL; Dujardin K; Reijnders JS; Defebvre L; Leentjens AF
    Parkinsonism Relat Disord; 2010 Dec; 16(10):656-60. PubMed ID: 20864380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factor structure, normative data and retest-reliability of a test of fine motor functions in patients with idiopathic Parkinson's disease.
    Ringendahl H
    J Clin Exp Neuropsychol; 2002 Jun; 24(4):491-502. PubMed ID: 12187462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationships among pain, depression, and sleep alterations in Parkinson's disease.
    Goetz CG; Wilson RS; Tanner CM; Garron DC
    Adv Neurol; 1987; 45():345-7. PubMed ID: 3825708
    [No Abstract]   [Full Text] [Related]  

  • 35. Pain in Parkinson's disease.
    Goetz CG; Tanner CM; Levy M; Wilson RS; Garron DC
    Mov Disord; 1986; 1(1):45-9. PubMed ID: 3504231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Qualitative assessment of Parkinson's disease: study of reliability and data reduction with an abbreviated Columbia Scale.
    Montgomery GK; Reynolds NC; Warren RM
    Clin Neuropharmacol; 1985; 8(1):83-92. PubMed ID: 3978653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative assessments of gait and mobility in Parkinson's disease.
    Stern GM; Franklyn SE; Imms FJ; Prestidge SP
    J Neural Transm Suppl; 1983; 19():201-14. PubMed ID: 6583307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Subjective blockage in Parkinson's disease].
    Volpe-Gillot L; Créange A; Degos JD
    Rev Neurol (Paris); 2002 Feb; 158(2):185-93. PubMed ID: 11965174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A qualitative analysis of mindfulness-based cognitive therapy (MBCT) in Parkinson's disease.
    Fitzpatrick L; Simpson J; Smith A
    Psychol Psychother; 2010 Jun; 83(Pt 2):179-92. PubMed ID: 19843353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Attribution processes of Parkinson patients in partner relations and the effects of anxiety].
    Döring J
    Psychother Psychosom Med Psychol; 1984 Jun; 34(6):140-7. PubMed ID: 6473681
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.